Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 37 holding rows worth $1,522,338,000.

Accession
0000919574-22-006773
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 37 entries on the cover page, a total value of $1,522,338,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,522,338,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
EQRX INC26886C107COM39,527,669$195,662,000thousands by filing date
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock7,566,292$172,133,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,225,000$135,412,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock648,000$129,704,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM1,700,000$112,013,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM3,178,167$109,170,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock4,683,432$104,768,000thousands by filing date
ILLUMINA INC452327109COM385,000$73,454,000thousands by filing date
MAXCYTE INC57777K106COM10,735,786$69,783,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock2,522,300$49,740,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM2,050,000$45,941,000thousands by filing date
SOMALOGIC INC83444K105COM12,604,275$36,552,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM3,206,380$31,711,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock967,000$31,418,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock995,000$30,537,000thousands by filing date
ABSCI CORPORATION00091E109COM7,718,593$24,159,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM370,000$17,627,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM250,000$17,460,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM295,000$16,508,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock1,650,000$16,319,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM750,000$15,668,000thousands by filing date
SEMA4 HOLDINGS CORP81663L101COM16,437,500$14,424,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM365,000$12,863,000thousands by filing date
TENAYA THERAPEUTICS INC87990A106COM3,586,818$10,402,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock614,754$8,945,000thousands by filing date
ARVINAS INC04335A105COM200,000$8,898,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM100,000$6,984,000thousands by filing datecall
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW165,000$4,638,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM510,882$4,174,000thousands by filing date
MODERNA INC60770K107COM32,500$3,843,000thousands by filing date
SINGULAR GENOMICS SYSTEMS IN82933R100COM1,345,722$3,364,000thousands by filing date
INVITAE CORP46185L103COM1,125,888$2,770,000thousands by filing date
CEREVEL THERAPEUTICS HLDNG I15678U128COM80,000$2,261,000thousands by filing date
EXSCIENTIA PLC30223G102ADS213,900$1,756,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock320,000$451,000thousands by filing date
KRONOS BIO INC50107A104COM123,839$415,000thousands by filing date
LIANBIO ADR53000N108COM206,415$411,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-22-006773this filing2022-11-14acceptance time not in the bulk data set